Literature DB >> 16376296

A cognitive behavioral workshop for subclinical obsessions and compulsions.

Bonnie G Zucker1, Michelle G Craske, Michelle A Blackmore, Ashley Nitz.   

Abstract

The present study investigates the effectiveness of a 3-h cognitive behavioral workshop for individuals, ages 18-22, with subclinical obsessions and compulsions. It was hypothesized that, compared to individuals in an assessment-only waitlist group (n = 42), individuals assigned to the workshop group (n = 43) would experience a significant decrease in obsessive-compulsive (OC) symptomatology, comorbidity, and thought action fusion endorsement at 1-month and 5-month follow-up assessments. An additional outcome of interest was the number of incident cases of obsessive-compulsive disorder (OCD) over the course of the study. The results indicated that the workshop group reported a significantly fewer number of OC symptoms at 5-month follow-up and endorsed significantly less thought action fusion at both follow-up points. However, there were no differences between groups in severity of OC symptoms and number of comorbid diagnoses endorsed. Only one incident case of OCD was observed during the study, from a participant in the waitlist group. These results are discussed in reference to treatment of subclinical anxiety symptoms.

Entities:  

Mesh:

Year:  2005        PMID: 16376296     DOI: 10.1016/j.brat.2005.03.015

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  2 in total

1.  Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions.

Authors:  Miguel A Fullana; David Mataix-Cols; Avshalom Caspi; Honalee Harrington; Jessica R Grisham; Terrie E Moffitt; Richie Poulton
Journal:  Am J Psychiatry       Date:  2009-02-02       Impact factor: 18.112

Review 2.  A Clinical Staging Model for Obsessive-Compulsive Disorder: Is It Ready for Prime Time?

Authors:  Leonardo F Fontenelle; Murat Yücel
Journal:  EClinicalMedicine       Date:  2019-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.